| Profitability | 16/100 |
| Growth | 40/100 |
| Momentum | 70/100 |
| Quality | 60/100 |
| Earnings Quality | 70/100 |
| Balance Sheet | 44/100 |
| Value | 35/100 |
| Risk (safety) | 80/100 |
| Overall | 46.5/100 |
| Symbol | IS Score |
|---|---|
| IQV | 56 |
| IDXX | 80 |
| ILMN | 58 |
| A | 71 |
| MTD | 63 |
| NTRA | 50 |
| WAT | 47 |
These two disagree — business quality 47, price structure 77 out of 100, so the price reads better than the business does. We publish the disagreement rather than resolving it: they answer different questions, and the gap between them is information, not an error.
| Trigger | Where it stands now | What it would mean |
|---|---|---|
| IS Score reaches 55 and holds two consecutive quarters | now 46.5 | would move us up one band |
| IS Score stops falling - one quarter higher than the prior | last four: 64 → 61 → 35 → 47 | the direction matters more than the level |
| Technical vote share back above 50% | now 64% | price structure no longer broken |
| Institutional holder count rises two quarters running | peak 1,189 → now 1,189 | fewer institutions willing to hold is our clearest warning |
This page is InsiderStreet's own reading, produced from the data in the rest of this document. It is not a price target and not investment advice. Analyst consensus and street price targets appear later under their own heading and are the street's numbers, not ours.
| Quarter | Holders | 13F shares | Value | Reported own% | Guard |
|---|---|---|---|---|---|
| 2026 Q2 | 1,189 | 98.8M | $35.1B | 100.6% | ex-outlier 92.0% |
| 2026 Q1 | 1,179 | 94.9M | $27.2B | 96.6% | |
| 2025 Q4 | 810 | 57.7M | $21.4B | 58.7% | |
| 2025 Q3 | 757 | 57.3M | $17.0B | 58.4% | |
| 2025 Q2 | 773 | 58.4M | $20.3B | 59.5% | |
| 2025 Q1 | 766 | 57.7M | $21.1B | 58.8% | |
| 2024 Q4 | 764 | 57.2M | $21.0B | 58.2% | |
| 2024 Q3 | 697 | 56.5M | $20.0B | 57.6% | |
| 2024 Q2 | 696 | 56.9M | $16.3B | 58.0% | |
| 2024 Q1 | 694 | 58.5M | $20.1B | 59.6% | |
| 2023 Q4 | 679 | 59.1M | $19.2B | 60.1% | |
| 2023 Q3 | 653 | 57.3M | $15.7B | 58.3% |
Why 2026-06 reads 100.60%. Institutions cannot hold more of a company than exists. The reported 98.8M shares exceed the 98.2M outstanding, and a single filer accounts for the excess: BlackRock, Inc. reports 8,484,939 shares against 8,543,014 the prior quarter, a 1x jump, which alone would be 8.6% of the company. Excluding that filing, ownership is 92.0%. We publish both figures. 13F filings are due 45 days after quarter end and amendments keep arriving after that, so the newest quarter is provisional by construction - this is what an unsettled quarter looks like.
| Insider | Role | Date | Type | Shares | Value | Post-Txn Owned |
|---|---|---|---|---|---|---|
| Knight Heather | director | 2026-09-30 | A-Award | 57 | — | 1,338 |
| Jiang Wei | director | 2026-09-30 | A-Award | 57 | — | 3,630 |
| Kuebler Christopher A | director | 2026-08-06 | EXERCISE | 3,626 | $0.49M | 21,434 |
| Kuebler Christopher A | director | 2026-08-06 | SELL | 3,626 | $1.44M | 17,808 |
| Kuebler Christopher A | director | 2026-08-06 | EXERCISE | 3,626 | $0.49M | 0 |
| Knight Heather | director | 2026-06-30 | A-Award | 63 | — | 1,281 |
| Jiang Wei | director | 2026-06-30 | A-Award | 67 | — | 3,573 |
| Carpio Robert L Iii | SVP Waters Analytical Sciences | 2026-06-24 | TAX W/H | 189 | $0.07M | 3,426 |
| 6-mo decomposition (Form 4) | Txns | Shares | Value | Signal weight |
|---|---|---|---|---|
| S — Open-market sales | 1 | 3,626 | $1.4M | Counted |
| P — Open-market purchases | 2 | 1,500 | $0.5M | Counted |
| M — Exercises (paired A/D) | 1 | 3,626 | $0.5M | None — mechanics |
| F — Tax withholding | 6 | 5,266 | $1.6M | None — compensation |
| Filed | Filer | Shares registered | Est. proceeds |
|---|---|---|---|
| 2026-08-06 | Kuebler Christopher A | 3,626 | $1.4M |
| 2024-05-15 | Kuebler Christopher A | 4,000 | $1.4M |
| 2024-03-13 | Baddour Linda | 500 | $0.2M |
| 2023-12-15 | Pratt Jonathan M | 2,116 | $0.7M |
| Trailing 12 mo | 1 filings | 3,626 | $1M |
| Filed | Form | Reporting person | % of class | Shares |
|---|---|---|---|---|
| 2026-05-15 | SCHEDULE 13G/A | Fundsmith LLP | 4.40% | 4.3M sh |
| 2026-04-30 | SCHEDULE 13G | Vanguard Capital Management | 7.49% | 7.4M sh |
| 2026-04-24 | SCHEDULE 13G/A | BlackRock, Inc. | 7.80% | 7.6M sh |
| 2026-03-27 | SCHEDULE 13G/A | The Vanguard Group | — | exit/reporting change |
| Member | Chamber | Trade | Size band | Traded | Disclosed |
|---|---|---|---|---|---|
| Kevin Hern | House | SELL | $1,001 - $15,000 | 2026-08-13 | 2026-09-02 |
| Kevin Hern | House | SELL | $1,001 - $15,000 | 2026-08-13 | 2026-09-02 |
| Kevin Hern | House | SELL | $1,001 - $15,000 | 2026-08-12 | 2026-09-02 |
| Tommy Tuberville | Senate | SELL | $1,001 - $15,000 | 2024-05-03 | 2024-06-14 |
| Tommy Tuberville | Senate | SELL | $1,001 - $15,000 | 2024-05-03 | 2024-06-13 |
| Thomas Hawley Tuberville | Senate | SELL | $1,001 - $15,000 | 2024-05-03 | 2024-06-13 |
| Manager | Shares | Value |
|---|---|---|
| Assenagon Asset Management S.A. | 140,202 | $62M |
| Schaper Benz & Wise Investment Cou | 102,776 | $45M |
| Fjarde Ap-Fonden /Fourth Swedish N | 33,877 | $15M |
| Mn Services Vermogensbeheer B.V. | 28,659 | $13M |
| Czech National Bank | 28,229 | $12M |
| Td Waterhouse Canada Inc. | 25,135 | $11M |
| Fund | Weight | Position |
|---|---|---|
| VITSX | 0.1% | $1.4B |
| VTI | 0.1% | $1.4B |
| VTSAX | 0.1% | $1.4B |
| VSMPX | 0.1% | $1.4B |
| VFIAX | 0.1% | $1.1B |
| VOO | 0.1% | $1.1B |
| ATS Venue (4-wk) | Shares | Avg trade |
|---|---|---|
| Incr Intelligent Cross Llc | 2.0M | 34 sh |
| Sgmt Sigma X2 | 1.2M | 33 sh |
| Mlix Instinct X | 0.9M | 52 sh |
| Ebxl Level Ats | 0.9M | 25 sh |
| Mstx Ms Trajectory Cross (Ats-1) | 0.7M | 25 sh |
| Mspl Ms Pool (Ats-4) | 0.7M | 78 sh |
| Region | Revenue | Share |
|---|---|---|
| Americas | $1.2B | 37% |
| Asia Pacific | $1.0B | 33% |
| Europe | $963M | 30% |
Moat score 34/100 — None; primary source Efficient Scale.
| Officer | Title |
|---|---|
| Udit Batra | President, Chief Executive Officer & Director |
| Amol Chaubal | Senior Vice President & Chief Financial Officer |
| Robert L. Carpio | Senior Vice President of Waters Analytical Sciences |
| Jianqing Y. Bennett | Senior Vice President of Waters Advanced Diagnostics Division |
| Period | EPS est. | EPS actual | EPS surprise | Rev est. ($M) | Rev actual ($M) | Rev surprise |
|---|
| YoY growth | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | +17.8% | +6.7% | -0.5% | +0.1% | +7.0% |
| Gross profit | +19.9% | +5.8% | +2.2% | -0.2% | +4.0% |
| Operating income | +27.3% | +6.3% | -6.4% | +1.1% | +8.1% |
| Net income | +32.8% | +2.2% | -9.3% | -0.7% | +0.8% |
| $B · FY ends | FY21 | FY22 | FY23 | FY24 | FY25 | Trend |
|---|---|---|---|---|---|---|
| Revenue | 2.8 | 3.0 | 3.0 | 3.0 | 3.2 | |
| Cost of revenue | 1.2 | 1.2 | 1.2 | 1.2 | 1.3 | |
| Gross profit | 1.6 | 1.7 | 1.8 | 1.8 | 1.8 | |
| R&D expense | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | |
| SG&A expense | 0.6 | 0.7 | 0.7 | 0.7 | 0.7 | |
| Operating income | 0.8 | 0.9 | 0.8 | 0.8 | 0.9 | |
| EBITDA | 1.0 | 1.0 | 1.0 | 1.0 | 1.0 | |
| D&A | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | |
| Pretax income | 0.8 | 0.8 | 0.7 | 0.8 | 0.8 | |
| Income tax | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| Net income | 0.7 | 0.7 | 0.6 | 0.6 | 0.6 | |
| Diluted EPS ($) | 11.17 | 11.73 | 10.84 | 10.71 | 10.76 | |
| Diluted shares (M) | 62 | 60 | 59 | 60 | 60 |
| $B | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|
| Cash & equivalents | 0.5 | 0.4 | 0.3 | 0.6 | |
| ST investments | 0.0 | 0.0 | 0.0 | 0.0 | |
| Receivables (net) | 0.7 | 0.7 | 0.7 | 0.8 | |
| Total current assets | 1.8 | 1.8 | 1.7 | 2.0 | |
| PP&E (net) | 0.7 | 0.7 | 0.7 | 0.6 | |
| Goodwill + intangibles | 0.7 | 1.9 | 1.9 | 1.9 | |
| Total assets | 3.3 | 4.6 | 4.6 | 5.1 | |
| Accounts payable | 0.1 | 0.1 | 0.1 | 0.0 | |
| Short-term debt | 0.1 | 0.1 | 0.0 | 0.0 | |
| Deferred revenue | 0.2 | 0.3 | 0.3 | 0.0 | |
| Total current liabilities | 0.8 | 0.8 | 0.8 | 0.0 | |
| Long-term debt | 1.5 | 2.3 | 1.6 | 1.4 | |
| Total liabilities | 2.8 | 3.5 | 2.7 | 2.5 | |
| Shareholders' equity | 0.5 | 1.2 | 1.8 | 2.6 |
| $B | FY22 | FY23 | FY24 | FY25 | |
|---|---|---|---|---|---|
| Net income | 0.7 | 0.6 | 0.6 | 0.6 | |
| D&A | 0.1 | 0.2 | 0.2 | 0.2 | |
| Stock-based compensation | 0.0 | 0.0 | 0.0 | 0.1 | |
| Working capital change | (0.3) | (0.2) | (0.1) | (0.3) | |
| Operating cash flow | 0.6 | 0.6 | 0.8 | 0.7 | |
| Capital expenditures | (0.2) | (0.2) | (0.1) | (0.1) | |
| Investing cash flow | (0.1) | (1.4) | (0.1) | (0.2) | |
| Buybacks | (0.6) | (0.1) | (0.0) | (0.0) | |
| Dividends paid | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt issuance / (repay) | 0.1 | 0.8 | (0.7) | (0.2) | |
| Financing cash flow | (0.5) | 0.8 | (0.7) | (0.2) | |
| Free cash flow | 0.4 | 0.4 | 0.6 | 0.5 |
| Ratio | FY21 | FY22 | FY23 | FY24 | FY25 | TTM | Trend |
|---|---|---|---|---|---|---|---|
| PROFITABILITY | |||||||
| ROE | 231.1% | 162.3% | 77.6% | 42.8% | 29.3% | 2% | |
| ROA | 23.3% | 22.2% | 16.2% | 13.9% | 13.3% | 0.7% | |
| ROIC | 50.5% | 43.7% | 22.3% | 21.8% | 21.2% | 1.3% | |
| Gross margin | 58.5% | 58.0% | 59.6% | 59.4% | 57.8% | 50.8% | |
| Operating margin | 29.5% | 29.4% | 27.7% | 27.9% | 28.2% | 8.0% | |
| Net margin | 24.9% | 23.8% | 21.7% | 21.6% | 20.3% | 3.6% | |
| EBITDA margin | 35.3% | 34.2% | 33.9% | 35.0% | 32.0% | 20.5% | |
| FCF margin | 20.8% | 14.7% | 15.0% | 20.9% | 17.1% | — | |
| VALUATION | |||||||
| P/E | 33.03 | 28.87 | 30.40 | 34.69 | 35.32 | 108.7 | |
| P/B | 62.27 | 40.50 | 16.97 | 12.10 | 8.86 | 2.8 | |
| P/S | 8.22 | 6.88 | 6.60 | 7.48 | 7.17 | 9.24 | |
| P/FCF | 39.53 | 46.86 | 44.16 | 35.71 | 42.05 | 107.7 | |
| EV/EBITDA | 24.34 | 21.25 | 21.55 | 22.68 | 22.95 | 50.1 | |
| EV/Revenue | 8.59 | 7.27 | 7.30 | 7.94 | 7.43 | 10.3 | |
| Earnings yield | 3.0% | 3.5% | 3.3% | 2.9% | 2.8% | 0.39% | |
| FCF yield | 2.5% | 2.1% | 2.3% | 2.8% | 2.4% | 0.93% | |
| Ratio | FY21 | FY22 | FY23 | FY24 | FY25 | TTM | Trend |
|---|---|---|---|---|---|---|---|
| LEVERAGE & SOLVENCY | |||||||
| Current ratio | 2.39 | 2.24 | 2.22 | 2.11 | — | 1.86 | |
| Quick ratio | 1.87 | 1.66 | 1.57 | 1.51 | — | 1.29 | |
| Debt / equity | 4.36 | 3.30 | 2.12 | 0.93 | 0.55 | 0.35 | |
| Debt / assets | 51.7% | 50.7% | 52.8% | 37.4% | 27.7% | 21.2% | |
| Net debt / EBITDA | 1.05 | 1.16 | 2.04 | 1.33 | 0.80 | 4.96 | |
| Interest coverage | 18.94 | 18.17 | 8.45 | 9.42 | 12.82 | — | |
| Ratio | FY21 | FY22 | FY23 | FY24 | FY25 | TTM | Trend |
|---|---|---|---|---|---|---|---|
| EFFICIENCY | |||||||
| Asset turnover | 0.94 | 0.93 | 0.75 | 0.64 | 0.66 | 0.19 | |
| Receivables turnover | 4.70 | 4.45 | 4.15 | 4.12 | 4.05 | 2.3 | |
| DSO (days) | 78 | 82 | 88 | 89 | 90 | 156 | |
| DPO (days) | 27 | 28 | 27 | 28 | 14 | 138 | |
| Cash conversion cycle | 155 | 173 | 209 | 212 | 223 | 238 | |
| GROWTH (YoY) | |||||||
| Revenue growth | 17.8% | 6.7% | -0.5% | 0.1% | 7.0% | — | |
| Net income growth | 32.8% | 2.2% | -9.3% | -0.7% | 0.8% | — | |
| EPS growth | 35.2% | 5.2% | -8.7% | -1.2% | 0.6% | — | |
| FCF growth | -6.3% | -24.7% | 1.4% | 40.1% | -12.9% | — | |
| PER SHARE ($) | |||||||
| EPS (diluted, TTM) | 11.28 | 11.87 | 10.83 | 10.69 | 10.75 | 1.69 | |
| Book value / share | 5.98 | 8.46 | 19.40 | 30.66 | 42.86 | 154.73 | |
| Revenue / share | 45.36 | 49.83 | 49.85 | 49.60 | 52.96 | 47.29 | |
| FCF / share | 9.43 | 7.31 | 7.46 | 10.39 | 9.03 | 4.06 | |
| Cash / share | 9.27 | 8.07 | 6.68 | 5.45 | 9.84 | 5.49 | |
| SHAREHOLDER RETURN & SCORES | |||||||
| Buyback yield | 2.8% | 3.1% | 0.4% | 0.1% | 0.1% | 0.04% | |
| Altman Z-Score | 10.74 | 10.20 | 7.62 | 9.37 | 7.02 | 3.6 | |
| Piotroski F-Score | 7 | 6 | 4 | 6 | 5 | 5/9 | |
| Beneish M-Score | -2.52 | -2.19 | -2.08 | -2.54 | -2.34 | -0.61 | |
| Model | Score | Zone | Note |
|---|---|---|---|
| Piotroski F-Score | 5 / 9 | Middling | |
| Altman Z-Score | 3.6 | Safe (>2.99) | Safe |
| Income quality | 3.31 | Cash-backed | OCF ÷ net income |
| Beneish M-Score | -0.61 | Elevated | vs −2.22 threshold |
| DuPont Decomposition (TTM) | Value |
|---|---|
| Tax burden | 0.81 |
| Interest burden | 0.61 |
| Operating margin | 7.3% |
| Asset turnover | 0.32× |
| Financial leverage | 1.70× |
| = ROE | 2% |
| Growth Quality (live) | Value |
|---|---|
| Revenue stability | 0.56 |
| Earnings stability | 0.49 |
| Earnings persistence | 0.50 |
| Revenue CAGR 3y | 15.8% |
| EPS CAGR 3y | -47.1% |
| FCF CAGR 3y | 1.0% |
| Company | Mkt cap | P/E | ROE | Net margin | Rev growth | Piotroski | 1-yr ret |
|---|---|---|---|---|---|---|---|
| IQV | $43.9B | 32.8 | 23% | 5.9% | +8.2% | 7/9 | +29.8% |
| IDXX | $44.1B | 39.4 | 74% | 27.8% | +12.8% | 9/9 | -12.1% |
| ILMN | $39.6B | 48.5 | 32% | 17.9% | +4.9% | 7/9 | +173.7% |
| A | $48.8B | 34.0 | 21% | 19.3% | +8.6% | 7/9 | +22.6% |
| MTD | $32.5B | 36.4 | -736% | 22.7% | +6.9% | 8/9 | — |
| NTRA | $56.7B | -289.3 | -13% | -8.9% | +37.8% | 6/9 | — |
| DGX | $25.9B | 24.6 | 14% | 10.5% | +9.9% | 8/9 | — |
| LH | $25.8B | 26.1 | 12% | 8.0% | +6.4% | 8/9 | — |
| Consensus estimates | Revenue mean | High / Low | EPS mean | High / Low | # EPS est. |
|---|---|---|---|---|---|
| FY2026 | $6.46B | $6.48B / $6.45B | $14.58 | $14.63 / $14.52 | 12 |
| FY2027 | $7.13B | $7.30B / $7.04B | $16.49 | $17.73 / $15.95 | 14 |
| FY2028 | $7.55B | $7.96B / $7.40B | $18.41 | $22.39 / $14.70 | 5 |
| Window | Avg Target | vs. Price | # Targets |
|---|---|---|---|
| Last Month | $501.67 | +14.8% | 3 |
| Last Quarter | $461.82 | +5.7% | 11 |
| Last Year | $425.97 | -2.5% | 29 |
| All Time | $404.29 | -7.5% | 45 |
| Moving Average | Value | Distance | % Distance | Signal |
|---|---|---|---|---|
| SMA 20 | $433.25 | +3.70 | +0.85% | Above |
| SMA 50 | $420.53 | +16.42 | +3.90% | Above |
| SMA 200 | $366.23 | +70.72 | +19.31% | Above |
| EMA 9 | $435.55 | +1.40 | +0.32% | Above |
| EMA 21 | $431.15 | +5.80 | +1.35% | Above |
| EMA 50 | $418.46 | +18.49 | +4.42% | Above |
| EMA 200 | $379.26 | +57.69 | +15.21% | Above |
| Level | Value | Level | Value |
|---|---|---|---|
| Pivot / R1 / R2 | $443.02 / $450.25 / $456.35 | S1 / S2 | $436.92 / $429.69 |
| Bollinger (20,2) | $419.73 – $446.76 | Squeeze | ON |
| 52-wk range | $282.77 – $454.54 | Off 52-wk high | -3.9% |
| ATR (14) | $12.68 (2.9%) | Historical vol | 25.3% |
| Computed from live weekly prices | WAT | S&P 500 |
|---|---|---|
| Weekly volatility (σ, 1y) | 4.91% | 1.83% |
| Best / worst week (1y) | +15.6% / -14.3% | — |
| Max drawdown (5y, monthly) | -37.4% | — |
| 1-week VaR (95%) | -8.5% | — |
| Beta (5y) | 1.19 | 1.00 |
| Reading | WAT | Medical - Diagnostics & Research n=227 | Healthcare n=5,272 | All US symbols n=70,435 |
|---|---|---|---|---|
| Overall | +16.8 | -17.0 | -24.0 | -20.5 |
| Trend | +42.5 | -7.2 | -25.6 | -21.3 |
| Momentum | +15.2 | -27.0 | -28.5 | -15.8 |
| Volume | +38.8 | +0.0 | -25.0 | -3.8 |
| Executive | Total comp | Structure |
|---|---|---|
| Udit Batra, Ph.D., President & CEO | $14.0M | 70% equity+incentive |
| Amol Chaubal, SVP & CFO | $3.8M | 65% equity+incentive |
| Jianqing Y. Bennett, SVP, TA & Clinical Divi | $3.0M | 61% equity+incentive |
| Robert Carpio III, SVP, Waters Division | $2.8M | 62% equity+incentive |
| Pillar (live disclosure scores) | Score |
|---|---|
| Environmental | 64 |
| Social | 67 |
| Governance | 78 |
| Composite ESG | 70 |
| Filed | 8-K contents | Items |
|---|---|---|
| 2026-08-21 | Officer/Director Change; Other Events | 5.02,8.01 |
| 2026-08-04 | Earnings Release; Exhibits | 2.02,9.01 |
| 2026-05-22 | Shareholder Vote | 5.07 |
| 2026-05-05 | Earnings Release; Exhibits | 2.02,9.01 |
| 2026-03-23 | Material Agreement; Financial Obligation; Other Events; Exhibits | 1.01,2.03,8.01,9.01 |
| 2026-03-16 | Other Events; Financial Statements and Exhibits | 8.01,9.01 |
| 2026-02-09 | Results of Operations and Financial Condition; Financial Statements an | 2.02,9.01 |
| 2026-02-09 | Entry into Material Definitive Agreement; Completion of Acquisition or | 1.01,2.01,2.03,5.02,7.01,9.01 |
Methodology. Every figure originates in InsiderStreet's production data layer and is computed deterministically by the same engines that power insiderstreet.ai. This factsheet contains no model-written text. Sections without underlying data are omitted rather than estimated.
| Data domain | Source | Coverage for this report |
|---|---|---|
| Price & volume | market_db.historical_prices | 52 rows |
| Fundamentals | income_statements_annual | 6 rows · 2020 to 2025 |
| Reported vs consensus | fact/earnings_calendar | 24 rows · 2020-10-27 to 2026-08-04 |
| Analyst estimates | dim/forward_estimates | 3 rows · 2026-12-31 to 2028-12-31 |
| Institutional ownership (13F) | holdings_db.institutional_ownership_summary | 114 rows · 1998 to 2026 |
| Insider transactions (Form 4) | edgar/form4 | 12 rows · 2026-03-31 to 2026-09-30 |
| Proposed sales (Form 144) | edgar/form144 | 1 record |
| Beneficial ownership (13D/G) | edgar/13dg | 4 rows · 2026-03-27 to 2026-05-15 |
| Short-sale volume (FINRA) | edgar/short_volume_daily | 60 rows · 2026-07-23 to 2026-10-15 |
| Dark pool (ATS, tier 1) | edgar/darkpool_weekly | 12 rows · 2026-06-15 to 2026-08-31 |
| ETF & fund holding | etf_holdings_changelog (30d) | 1 record |
| Peer set | stock_peers_dynamic | 8 rows |
| Industry medians | industry_medians | 1 record |
| Congressional trades | congress_db (House + Senate) | 1 record |
| ESG | fact/esg_disclosures | 1 record |
Method. Every figure in this factsheet is looked up from a named field computed in code. It contains no model-written text.
Not covered. Short interest as a percent of float and days-to-cover are not in this data set — the short-sale figures above are FINRA volume, a flow, and cannot support squeeze or covering analysis. Options positioning and intraday data are also absent. 13F ownership is filed 45 days after quarter end and congressional trades are disclosed on a lag, so both describe a past position, not a current one.